{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-217452","form_type":"8-K","ticker":"TNYA","cik":"0001858848","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2022-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.487849+00:00","generated_at":"2026-06-24T01:35:43.175662+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tenaya Therapeutics enters $75M at-the-market equity sales agreement with SVB Securities","bullets":["Aggregate sales proceeds up to $75M from common stock sold through ATM program.","SVB Securities receives 3.0% commission on gross proceeds as sales agent.","Company sets parameters including price and volume; no obligation to sell shares.","Shares issued under shelf registration statement filed August 10, 2022.","Agreement can be terminated by either party on 10 days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-217452","json":"https://secwatch.observer/filing/0001193125-22-217452.json","markdown":"https://secwatch.observer/filing/0001193125-22-217452.md","text":"https://secwatch.observer/filing/0001193125-22-217452.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000119312522217452/0001193125-22-217452-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000119312522217452/d301698d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T01:35:43.175662+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}